Will This ETF Beat the Market Over the Next 12 Months?
2024 was another banner year for the US stock market,…
Sell
48
BME Quote, Financials, Valuation and Earnings
Last price:
$38.30
Seasonality move
:
0.06%
Day range:
$37.60 - $38.46
52-week range:
$36.87 - $42.86
Dividend yield:
6.8%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
75.4K
Avg. volume:
77.1K
1-year change:
-6.88%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Analysts' Opinion
-
Consensus RatingBlackrock Health Sciences Trust has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Blackrock Health Sciences Trust has an estimated downside of -- from its current price of $38.30.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $38.30.
Fair Value
-
According to the consensus of 0 analysts, Blackrock Health Sciences Trust has -- downside to fair value with a price target of -- per share.
BME vs. S&P 500
-
Over the past 5 trading days, Blackrock Health Sciences Trust has overperformed the S&P 500 by 0.03% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Blackrock Health Sciences Trust does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Blackrock Health Sciences Trust has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Blackrock Health Sciences Trust reported revenues of --.
Earnings Growth
-
Blackrock Health Sciences Trust has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Blackrock Health Sciences Trust reported earnings per share of --.
Enterprise value:
--
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-01-04 | 2024-01-04 | 2024-01-04 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | $837.5K | $944.4K | $1.3M | |
| Total Assets | -- | -- | $355.5M | $453.4M | $554.6M | |
| Current Liabilities | -- | -- | $1.3M | $742.4K | $588.7K | |
| Total Liabilities | -- | -- | $2.8M | $6.6M | $8.6M | |
| Total Equity | -- | -- | $352.7M | $446.8M | $545.9M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-01-04 | 2024-01-04 | 2024-01-04 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
BME
Sector
Market Cap
--
--
Price % of 52-Week High
89.36%
--
Dividend Yield
6.8%
--
Shareholder Yield
--
--
1-Year Price Total Return
-6.88%
--
Beta (5-Year)
0.684
--
Dividend yield:
6.8%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$38.03
200-day SMA
Sell
Level
$40.41
Bollinger Bands (100)
Sell
Level
0 - 0
Chaikin Money Flow
Sell
Level
--
20-day SMA
Sell
Level
$38.30
Relative Strength Index (RSI14)
Sell
Level
47.38
ADX Line
Neutral
Level
0
Williams %R
Neutral
Level
-25.5222
50-day SMA
Sell
Level
$39.31
MACD (12, 26)
Sell
Level
-0.43
25-day Aroon Oscillator
Sell
Level
-60
On Balance Volume
Neutral
Level
--
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (6)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.
Stock Forecast FAQ
In the current month, BME has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The BME average analyst price target in the past 3 months is --.
-
Where Will Blackrock Health Sciences Trust Stock Be In 1 Year?
According to analysts, the consensus estimate is that Blackrock Health Sciences Trust share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Blackrock Health Sciences Trust?
Analysts are divided on their view about Blackrock Health Sciences Trust share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Blackrock Health Sciences Trust is a Sell and believe this share price will rise from its current level to --.
-
What Is Blackrock Health Sciences Trust's Price Target?
The price target for Blackrock Health Sciences Trust over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is BME A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Blackrock Health Sciences Trust is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of BME?
You can purchase shares of Blackrock Health Sciences Trust via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Blackrock Health Sciences Trust shares.
-
What Is The Blackrock Health Sciences Trust Share Price Today?
Blackrock Health Sciences Trust was last trading at $38.30 per share. This represents the most recent stock quote for Blackrock Health Sciences Trust. Yesterday, Blackrock Health Sciences Trust closed at $38.30 per share.
-
How To Buy Blackrock Health Sciences Trust Stock Online?
In order to purchase Blackrock Health Sciences Trust stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Carlos Slim Buy PBF Energy?
Carlos Slim made a splash in a surprising sector last…
Is Booking Holdings Stock Undervalued?
There is a lot of humdrum in the market about…
Stock Ideas
Sell
48
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 116x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Sell
45
DRUG alert for Jan 4
Bright Minds Biosciences [DRUG] is down 4.28% over the past day.
Buy
85
BMA alert for Jan 4
Banco Macro SA [BMA] is up 0.88% over the past day.
Sell
47
AGFY alert for Jan 4
Agrify [AGFY] is down 5.86% over the past day.
